Viruses · 2024 · 11 citations · 18 references
Veterinary MedicineInfectious DiseasesPediatricsInfectious Disease EpidemiologyPediatric EpidemiologyPediatric Infectious DiseasesHealthcare-associated InfectionsRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Tract InfectionsCohort Study InvestigationOdds Ratio ModelingPediatric Viral InfectionsRespiratory Infections In ChildrenRespiratory Viral InfectionsRespiratory VirusesSars-cov-2 InfectionViral Respiratory Infections
Respiratory tract infections (RTIs) are the most common infectious syndromes, primarily caused by viruses. The primary objective was to compare the illness courses between historical RTIs and recent SARS-CoV-2 infections. The study cohort consisted of RTI cases evaluated at the Pediatric Emergency Departments of Padua and Bologna, discharged or admitted with microbiologically confirmed viral RTI between 1 November 2018 and 30 April 2019 (historical period) and 1 March 2020 and 30 April 2021 (recent period). We evaluated the risk of oxygen or respiratory support, hospitalization, antibiotic therapy, and complications among different viral infections. The odds ratio (OR) and the 95% confidence intervals (CIs) were estimated through mixed-effect logistic regression models, including a random intercept on the individual and hospital. We identified 767 RTIs: 359 in the historical period compared with 408 SARS-CoV-2 infections. Infections of SARS-CoV-2 had a lower risk of being admitted (OR 0.04, 95% CI 0.03-0.07), receiving respiratory support (OR 0.19, 95% CI 0.06-0.58), needing antibiotic therapy (OR 0.35, 95% CI 0.22-0.56) and developing complications (OR 0.27, 95% CI 0.14-0.51) compared to all other viral RTIs. COVID-19 in children is clinically similar to other viral RTIs but is associated with a less severe infection course. Thus, most prevention strategies implemented for SARS-CoV-2 should still be considered during RSV and Influenza epidemics.
18
Haiyan Qiu, Junhua Wu, Liang Hong et al. · The Lancet Infectious Diseases · 2020 · 1.4K citations · Full text
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
Simon B. Drysdale, Katrina Cathie, Florence Flamein et al. · New England Journal of Medicine · 2023 · 348 citations · Full text
Ilari Kuitunen, Miia Artama, Lotta Mäkelä et al. · The Pediatric Infectious Disease Journal · 2020 · 332 citations